Jacob E. Berchuck, MD, discusses how a new epigenomic platform may influence the accessibility of PSMA-based therapies, especially for patients who may not have easy access to PSMA PET scans.
PSMA-PET imaging has higher sensitivity than conventional imaging and can detect radiorecurrent prostate cancer at lower PSA levels. PSMA-PET imaging can detect radiorecurrent prostate cancer ...
Gozetotide is a drug for diagnostic application in adults with prostate cancer. It is currently the only diagnostic agent that recognizes PSMA-positive prostate cancer and can therefore identify ...
The abbreviation PSMA stands for prostate-specific membrane antigen: a protein that ... labelled and thus visualizes the cancer cells during a PET scan. The health-related benefits or harms ...
Gozetotide is a drug for diagnostic application in adults with prostate cancer. It is currently the only diagnostic agent that recognizes PSMA-positive prostate cancer and can therefore identify ...
Since then, MSK has continued to play a critical role in developing and testing this technology to track and treat spreading prostate cancer cells, which would otherwise be hidden. (Left) PSMA PET ...